i
Interim guidelines for collection, processing and transport of clinical specimens from patients under investigation for Middle East Respiratory Syndrome (MERS)
-
June 7, 2013
[PDF-179.59 KB]
Details:
-
Alternative Title:Interim laboratory biosafety guidelines for handling and processing specimens associated with MERS-CoV
-
Corporate Authors:
-
Description:Before collecting and shipping specimens for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) testing, determine whether the patient meets the current definition for MERS “Patient Under Investigation” prepared by the Centers for Disease Control and Prevention (CDC).
Specimen Type and Priority To date, little is known about pathogenic potential and transmission dynamics of MERS-CoV. To increase the likelihood of detecting infection, it is recommended to collect specimens from different sites – for example a nasopharyngeal swab and a lower respiratory tract specimen such as sputum, bronchoalveolar lavage, bronchial wash, or tracheal aspirate. Specimens should be collected at different times after symptom onset, if possible. Consider lower respiratory tract, serum, and stool specimens a priority for collection and PCR testing.
-
Subject:
-
Document Type:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
-
No Additional Files
More +
You May Also Like
[PDF - 375.83 KB]
Email
CDC-INFO
